From filing to price impact: microstructure, currency-normalised comparisons, walk-forward design.
Two Sanofi executives bought stock on August 24 after a stronger July 30 quarter and a raised 2026 outlook. Here is the context.
Guardant Health’s CEO sold EUR 3.0m after a strong biotech week. We compare the filing with Natera, valuation, and the cluster around GH.
Alliance Laundry's BDT-led $590m sale lands beside a steady laundry market, a mixed insider cluster, and a stock still near the low $20s.
Tinexta's August 24 buy cluster came as guidance was cut, the stock sat near EUR 15, and Italian markets stayed cautious.
Tikehau Capital’s insider buying cluster comes as private credit and thematic strategies keep the Paris manager’s H1 momentum alive.
Sanofi’s August 24 executive buys land after stronger Q2 guidance and a firmer Paris share price. Here is what the cluster adds, and what it does not.
Hexagon’s board buy lands after 12% organic growth, a stronger Q2 and a recent insider cluster. Here is what the filing adds, and what it does not.
Alibaba directors bought after a mixed Q1: cloud grew 45%, capex jumped 75%, and the stock still trades against PDD and JD.
Amotiv director Jennifer Anne Douglas bought EUR 12,040 after FY26 shares fell 14%. Read the cluster, the outlook, and the sector backdrop.
Deutsche Bank trades near €32.50 while the July 29 buyback and a strong European bank backdrop keep the stock in focus, with no fresh insider prints.
Bayer trades near €48 as Roundup timing, Q2 progress and a quiet insider tape keep the legal discount in focus versus Pfizer.
BASF is leaning on buybacks, specialty price hikes and portfolio exits while Rhine logistics stay awkward. The insider record is quiet.